Editorial: RNA recognition landscapes and anticancer drug targeting
Erica Salvati1, Anna Lewinska2, Erik Dassi3
1Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy.
Frontiers in Oncology
|July 5, 2023
Abstract
No abstract available in PubMed .
Keywords:
RNARNA-binding proteinsanti-canceranti-inflammatorydrugmechanism of action (MOA)post-transcriptional control

